Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial

Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial

Abstract Background Patients with both diabetes mellitus (DM) and chronic kidney disease (CKD) are a subpopulation characterized by ultrahigh ischemic and bleeding risk after percutaneous coronary intervention. There are limited data on the impact of ticagrelor monotherapy among these patients. Meth...

Full description

Bibliographic Details
Main Authors:	Chao Gao, Mariusz Tomaniak, Kuniaki Takahashi, Hideyuki Kawashima, Rutao Wang, Hironori Hara, Masafumi Ono, Gilles Montalescot, Scot Garg, Michael Haude, Ton Slagboom, Pascal Vranckx, Marco Valgimigli, Stephan Windecker, Robert-Jan van Geuns, Christian Hamm, Philippe Gabriel Steg, Yoshinobu Onuma, Dominick J. Angiolillo, Patrick W. Serruys
Format:	Article
Language:	English
Published:	BMC 2020-10-01
Series:	Cardiovascular Diabetology
Subjects:	Chronic kidney disease Diabetes mellitus Percutaneous coronary intervention DAPT Ticagrelor Aspirin-free antiplatelet strategies
Online Access:	http://link.springer.com/article/10.1186/s12933-020-01153-x

Similar Items

Einfluss der präoperativen Gabe des neuen Thrombozytenaggregationshemmers Ticagrelor auf die peri- und postoperative Phase bei koronarchirurgischen Patienten mit Herzlungenmaschine
by: Meyer-Albert, Katharina
Published: (2018)

Ticagrelor
by: Gianluca Airoldi, et al.
Published: (2013-03-01)

Ticagrelor versus clopidogrel in the management of acute myocardial infarction
by: Candice Volney, et al.
Published: (2019-07-01)

No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy
by: Viviana Laredo, et al.
Published: (2020-05-01)

Platelet inhibition during ticagrelor monotherapy versus ticagrelor plus aspirin in patients with coronary artery disease (TEMPLATE study): study protocol for a randomised controlled trial
by: Sarah Baos, et al.
Published: (2017-11-01)

Aspirin or Ticagrelor in Staphylococcus aureus Infective Endocarditis: Where Do We Stand?
by: Kirsten Leeten, et al.
Published: (2021-10-01)

Strategic approach to developing a self-microemulsifying drug delivery system to enhance antiplatelet activity and bioavailability of ticagrelor
by: Na YG, et al.
Published: (2019-02-01)

A cost-effectiveness and safety analysis of dual antiplatelet therapy comparing aspirin–clopidogrel to aspirin–ticagrelor in patients with acute coronary syndrome
by: Nafrialdi Nafrialdi, et al.
Published: (2018-12-01)

Spontaneous subdural hematoma and antiplatelet therapy: Does efficacy of Ticagrelor come with added risk?
by: Pattanagere Manjunatha Suryanarayana Sharma, et al.
Published: (2015-12-01)

Comparative <i>In Vitro</i> Study of Various α<sub>2</sub>-Adrenoreceptor Agonist Drugs for Ticagrelor Reversal
by: Guillaume Porta Bonete, et al.
Published: (2020-03-01)

Ticagrelor – toward more efficient platelet inhibition and beyond
by: Kubisa MJ, et al.
Published: (2018-01-01)

Systemic Design and Evaluation of Ticagrelor-Loaded Nanostructured Lipid Carriers for Enhancing Bioavailability and Antiplatelet Activity
by: Gi-Ho Son, et al.
Published: (2019-05-01)

Comparisons between ticagrelor and clopidogrel following percutaneous coronary intervention in patients with acute coronary syndrome: a comprehensive meta-analysis
by: Fan ZG, et al.
Published: (2019-02-01)

Ticagrelor in patients with stable coronary artery disease: a role in improving prognosis
by: T. N. Novikova
Published: (2020-09-01)

Validating Utility of Dual Antiplatelet Therapy Score in a Large Pooled Cohort From 3 Japanese Percutaneous Coronary Intervention Studies
by: Yoshikawa, Yusuke
Published: (2020)

ALTERNATIVE APPROACHES TO THE USE OF TWO COMPONENT ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME: EVIDENCES, RECOMMENDATIONS AND REAL PRACTICE
by: S. R. Gilyarevskiy, et al.
Published: (2015-12-01)

PROLONGED DUAL ANTIPLATELET THERAPY AFTER MYOCARDIAL INFARCTION: WHAT THE RESULTS OF THE PEGASUS-TIMI 54 TRIAL SHOW
by: I. S. Yavelov
Published: (2017-09-01)

The Role of Ticagrelor in STEMI Fibrinolytic and Its Rationale to Utilize for Indonesian Patients
by: Daniel Tobing, et al.
Published: (2019-09-01)

Reacción de hipersensibilidad a ticagrelor
by: Jorge Alberto Castro Clavijo, et al.
Published: (2020-02-01)

Validation of an HPLC–MS/MS Method for the Determination of Plasma Ticagrelor and Its Active Metabolite Useful for Research and Clinical Practice
by: Jennifer Lagoutte-Renosi, et al.
Published: (2021-01-01)

The choice of the P2Y12 receptors blocker in the treatment of a patient with acute coronary syndrome: practice of N.I. Pirogov city clinical hospital №1
by: M. R. Atabegashvili, et al.
Published: (2019-04-01)

Oral Antiplatelet Therapy for Secondary Prevention of Non-Cardioembolic Ischemic Cerebrovascular Events
by: Leonardo De Luca, et al.
Published: (2021-04-01)

Patient after myocardial infarction: how to reduce the risk of recurrent ischemic events?
by: O. L Barbarash, et al.
Published: (2015-06-01)

Safety of Ticagrelor Compared to Clopidogrel after Prehospital Initiation of Treatment
by: Thomas O. Bergmeijer, et al.
Published: (2018-10-01)

Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long‐Term Ticagrelor in Stable Patients With Prior Myocardial Infarction
by: Giulia Magnani, et al.
Published: (2021-02-01)

Ticagrelor Use in Stroke Patients: Past, Present, and Future
by: Chandra R, et al.
Published: (2021-06-01)

Ticagrelor in Patients With Cancer
by: Roxana Mehran, MD, et al.
Published: (2020-06-01)

Desenvolvimento de método analítico para avaliação de impurezas orgânicas de ticagrelor
by: Bueno, Lívia Maronesi
Published: (2017)

Desenvolvimento de método analítico para avaliação de impurezas orgânicas de ticagrelor
by: Bueno, Lívia Maronesi
Published: (2017)

Desenvolvimento de método analítico para avaliação de impurezas orgânicas de ticagrelor
by: Bueno, Lívia Maronesi
Published: (2017)

Dual Antiplatelet Therapy in Coronary Artery Disease
by: Raghav Sharma, et al.
Published: (2020-08-01)

Clopidogrel in the treatment of patients with ST-elevation acute myocardial infarction: state-of-art in 2013
by: O. V. Averkov
Published: (2013-02-01)

INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION
by: E. V. Tavlueva, et al.
Published: (2017-11-01)

Impact of Crystal Habit on Solubility of Ticagrelor
by: Yan Ren, et al.
Published: (2019-10-01)

Aspirin-free antithrombotic management following coronary stenting. Myth or reality?
by: Davide Capodanno, et al.
Published: (2019-02-01)

Use of Clopidogrel, Prasugrel, or Ticagrelor and Patient Outcome after Acute Coronary Syndrome in Austria from 2015 to 2017
by: Safoura Sheikh Rezaei, et al.
Published: (2020-10-01)

Incidence and Risk Factors for Antiplatelet Therapy–Related Bleeding Complications Among Elderly Patients After Coronary Stenting: A Multicenter Retrospective Observation
by: Yanxia Qian, et al.
Published: (2021-07-01)

Ticagrelor: clinical development and future potential
by: Nicholas C. Sanderson, et al.
Published: (2021-06-01)

Preparation and Characterization of Novel Pharmaceutical Co-Crystals: Ticagrelor with Nicotinamide
by: Muhammad Inam, et al.
Published: (2018-08-01)

Pharmacokinetics, Bioequivalence and Safety Evaluation of Two Ticagrelor Tablets Under Fasting and Fed Conditions in Healthy Chinese Subjects
by: Wang J, et al.
Published: (2021-03-01)